BIO-key holds reconvened annual stockholder meeting; Proposal 4 vote remains open
BKYI•BIO-key held its reconvened annual stockholder meeting on Oct. 2, 2026. Shareholders approved the director slate and auditor, while a vote on issuing up to 1,236,668 shares upon warrant exercises was adjourned.
1. Meeting votes
Shareholders backed the director nominees for service through the 2027 annual meeting and ratified M&K CPAs, PLLC as BIO-key’s independent registered public accounting firm for the year ending Dec. 31, 2026. A separate vote to authorize issuance of up to 1,236,668 shares upon warrant exercises was adjourned, with no outcome reported.
